Roche obtains license for EGFR lung cancer assays and will develop Tarceva companion diagnostic test
23 November 2010 | By F. Hoffmann-La Roche Ltd
Roche obtained a worldwide sublicense from Genzyme Corporation to develop a diagnostic assay for the detection of EGFR mutations...